- Filed
- Nov 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Nov 11, 2025 | 13.72M sh |
| Shares Diluted | Q2 2026 · Sep 30, 2025 | 13.32M sh |
| Shares Diluted | Q2 2026 · Sep 30, 2025 | 11.27M sh |
| Shares Diluted restated | Q2 2026 · Sep 30, 2024 | 4.79M sh |
| Shares Diluted restated | Q2 2026 · Sep 30, 2024 | 4.79M sh |
| Capex | Q2 2026 · Sep 30, 2025 | $1.61M |
| Capex | Q2 2026 · Sep 30, 2024 | $3.23M |
| Operating Cash Flow | Q2 2026 · Sep 30, 2025 | −$32.49M |
| Operating Cash Flow | Q2 2026 · Sep 30, 2024 | −$17.19M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $14.67M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2025 | $16.46M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2024 | $16.72M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | −$160.5M |
| Stockholders Equity | Q2 2026 · Jun 30, 2025 | −$114.39M |
| Stockholders Equity | Q2 2026 · Mar 31, 2025 | −$164.37M |
| Stockholders Equity restated | Q2 2026 · Sep 30, 2024 | −$151.1M |
| Stockholders Equity restated | Q2 2026 · Jun 30, 2024 | −$140.33M |
| Stockholders Equity | Q2 2026 · Mar 31, 2024 | −$121.5M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $241.75M |
| Current Liabilities | Q2 2026 · Mar 31, 2025 | $257.61M |
| Current Liabilities restated | Q2 2026 · Sep 30, 2024 | $130.73M |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $298.2M |
| Total Liabilities | Q2 2026 · Mar 31, 2025 | $319.77M |
| Total Liabilities restated | Q2 2026 · Sep 30, 2024 | $314.25M |
| Current Assets | Q2 2026 · Sep 30, 2025 | $90.13M |
| Current Assets | Q2 2026 · Mar 31, 2025 | $102.81M |
| Total Assets | Q2 2026 · Sep 30, 2025 | $137.7M |
| Total Assets | Q2 2026 · Mar 31, 2025 | $155.4M |
| Eps Diluted | Q2 2026 · Sep 30, 2025 | −$3.49 |
| Eps Diluted | Q2 2026 · Sep 30, 2025 | −$5.65 |
| Eps Diluted restated | Q2 2026 · Sep 30, 2024 | −$2.54 |
| Eps Diluted restated | Q2 2026 · Sep 30, 2024 | −$6.69 |
| Eps Basic | Q2 2026 · Sep 30, 2025 | −$3.49 |
| Eps Basic | Q2 2026 · Sep 30, 2025 | −$5.65 |
| Eps Basic restated | Q2 2026 · Sep 30, 2024 | −$2.54 |
| Eps Basic restated | Q2 2026 · Sep 30, 2024 | −$6.69 |
| Sga Expense | Q2 2026 · Sep 30, 2025 | $11.01M |
| Sga Expense | Q2 2026 · Sep 30, 2025 | $24.58M |
| Sga Expense | Q2 2026 · Sep 30, 2024 | $13.98M |
| Sga Expense restated | Q2 2026 · Sep 30, 2024 | $35.04M |
| Rd Expense | Q2 2026 · Sep 30, 2025 | $5.69M |
| Rd Expense | Q2 2026 · Sep 30, 2025 | $12.35M |
| Rd Expense | Q2 2026 · Sep 30, 2024 | $8.26M |
| Rd Expense | Q2 2026 · Sep 30, 2024 | $16.57M |
| Net Income | Q2 2026 · Sep 30, 2025 | −$46.46M |
| Net Income | Q2 2026 · Sep 30, 2025 | −$63.66M |
| Net Income restated | Q2 2026 · Sep 30, 2024 | −$12.15M |
| Net Income restated | Q2 2026 · Sep 30, 2024 | −$32.05M |
| Operating Income | Q2 2026 · Sep 30, 2025 | −$8.16M |
| Operating Income | Q2 2026 · Sep 30, 2025 | −$20.75M |
| Operating Income restated | Q2 2026 · Sep 30, 2024 | −$5.56M |
| Operating Income restated | Q2 2026 · Sep 30, 2024 | −$22.36M |
| Gross Profit | Q2 2026 · Sep 30, 2025 | $23.55M |
| Gross Profit | Q2 2026 · Sep 30, 2025 | $46.27M |
| Gross Profit restated | Q2 2026 · Sep 30, 2024 | $30.65M |
| Gross Profit restated | Q2 2026 · Sep 30, 2024 | $57.7M |
| Revenue | Q2 2026 · Sep 30, 2025 | $62.72M |
| Revenue | Q2 2026 · Sep 30, 2025 | $127M |
| Revenue restated | Q2 2026 · Sep 30, 2024 | $71.85M |
| Revenue restated | Q2 2026 · Sep 30, 2024 | $144.11M |